ISPO

Dietary Influences

The in vivo antitumor activity of vitamin C : K_(3) combinations against human prostate cancer correlates with their abilities to reactivate DNases

JM Jamison, PhD HS Taper, MD, PhD J Gilloteaux, DSc JL Summers, MD, PhD^

Vitamin E succinate promotes prostate tumor dormancy

MP Malafa, MD, FD Fokum, PhD, J Andoh, BS, LT Neitzel, MS, G Goodarzi PhD, K Watabe PhD

Growth inhibition of colorectal liver metastases by combretastatin A4 prodrug (CA4P)

D. Kuruppu PhD, V. Muralidharan FRACS, C.M. Malcontenti-Wilson BSc, A. Misajon MSc, S. Skinner FRACS, PhD, C. Christophi FRACS, MD, P.E. O'Brien, MD, FRACS.

In vitro analysis of the anti-prostatic properties of dietary supplement EquiguardTM with herbal formulation PC-SPES.

JM Wu, PhD, TC Hsieh, PhD

Estrogen epoxidation as the molecular basis for breast cancer initiation and prevention

F Yu, PhD

Diallyl disulfide induces STAT1 gene expression in human colon tumor cells (colo 205)

JG Chung, PhD, WL Wang, HF Lu, GW Chen PhD, HC Ho PhD

Solution structure of the 2-amino-1-methyl-6-phenylimidazo [4,5-b]pyridine (PhIP)-C8-dG adduct opposite dC in a DNA duplex

K Brown,PhD, E Guenther, PhD, BE Hingerty,PhD, S Broyde, PhD, K Turteltaub,PhD, M Cosman,PhD,

Nutrient interactions in human and Caco-2 cells

R.I. Kushak, Ph.D., DSc., H.S. Winter, MD

Gene-nutrient interactions and risk of human papillomavirus (HPV) persistence

CJ Piyathilake, PhD, , OL Henao, MS,, S Meleth, PhD,, GL Johanning, PhD , PE Cornwell, PhD, , EE Partridge, MD, ,and DC Heimburger, MD,

Metformin clearly inhibits pancreatic cancer

M.B.Schneider MD, J. Standop MD, H. Matsuzaki MD, J. Haorah MD, A. Ulrich MD, and P.M. Pour MD.

A diacetylenic spiroketal enol ether epoxide from Artemisia lactiflora inhibits 12-O-tetradecanoylphorbol-13-acetate-induced tumor promotion

Y Nakamura, PhD,, A Murakami, PhD,, H Ohigashi, PhD,.

Chemopreventive effect of lycopene on cytotoxicity of T-2 toxin in vivo

M. Leal a, E. González de Mejíaa , V. Tsutsumib, A. Shimadac and F. Ruizc

Influence of PUFA on immune cell MAPK: A prospective cancer biomarker

KE Saker, BE Cowing, WR Huckle, I Paetau-Robinson

Prospective randomised multicentre clinical trial on the use of PUVA monotherapy versus PUVA plus interferon alfa 2a in patients with cutaneous T-Cell lymphoma

R. Stadler Prof , J. Bohmeyer Dr. , T. Luger Prof , W. Sterry Prof